Keefe, Bruyette & Woods Maintains Outperform on MetLife, Raises Price Target to $98

Benzinga Newsdesk www.benzinga.com Positive 89.2%

Neg 0% Neu 0% Pos 89.2%

Keefe, Bruyette & Woods analyst Ryan Krueger maintains MetLife (NYSE:MET) with a Outperform and raises the price target from $87 to $98.